| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
|
|
|
|||||||
|
|||||||||
The Journal of Immunology, Vol 143, Issue 3 798-801, Copyright © 1989 by American Association of Immunologists
ARTICLES |
S Huet, H Groux, B Caillou, H Valentin, AM Prieur and A Bernard
Laboratoire d'Immunologie des Tumeurs de l'Enfant, Institut Gustave- Roussy, Villejuif, France.
We demonstrate here that the CD44 molecule, which mediates lymphocyte adhesion to high endothelial venules (HEV), is also involved in the delivery of an activation signal to the T cell. We have produced a CD44 mAb (H90) which is able to block the binding of lymphocytes to high endothelial venules. H90 had no effect on [3H]TdR incorporation of whole PBL stimulated by lectins, allogeneic cells, or CD3 mAb in the soluble phase; in contrast, it strongly increased [3H]TdR incorporation of PBL stimulated by CD2 pairs of mAb or by CD3 mAb linked to the plastic culture plates, when purified T cells were used, H90 mAb could efficiently induce them to proliferate after a primary signal of activation delivered via cross-linked CD3 or via CD2, an effect mediated by Il-2 synthesis and Il-2R expression. Thus, the effect of H90 mAb resembles the mitogenic effect of CD28 "9.3" mAb. However, several results show that CD28 and CD44 mediate different signals to the T cells: i) in contrast to CD28 mAb, CD44 mAb cannot complement the signal delivered by a soluble CD3 mAb, lectins, or PMA; ii) CD44 mAb, at the difference of CD28 mAb, cannot induce CD3+ thymocytes to proliferate in conjunction with a first signal provided via cross- linked CD3 or via CD2; iii) F(ab) fragments of H90 were efficient, whereas divalent fragments of CD29 9.3 mAb are required to produce activation signals; and iv) CD44 and CD28 mAb produce a very strong synergistic effect on T cell proliferation. These results fit with previous ones showing that endothelial cells can play the role of accessory cell in T cell activation and that a hierarchy of signaling can be delivered to T cells via CD3 and CD2.
This article has been cited by other articles:
|
|
 |
|
  V. L. Hegde, N. P. Singh, P. S. Nagarkatti, and M. Nagarkatti CD44 mobilization in allogeneic dendritic cell-T cell immunological synapse plays a key role in T cell activation J. Leukoc. Biol., July 1, 2008; 84(1): 134 - 142. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 P. Huebener, T. Abou-Khamis, P. Zymek, M. Bujak, X. Ying, K. Chatila, S. Haudek, G. Thakker, and N. G. Frangogiannis CD44 Is Critically Involved in Infarct Healing by Regulating the Inflammatory and Fibrotic Response J. Immunol., February 15, 2008; 180(4): 2625 - 2633. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 A. A. Belperron, C. M. Dailey, C. J. Booth, and L. K. Bockenstedt Marginal Zone B-Cell Depletion Impairs Murine Host Defense against Borrelia burgdorferi Infection Infect. Immun., July 1, 2007; 75(7): 3354 - 3360. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
J. Larkin, G. J. Renukaradhya, V. Sriram, W. Du, J. Gervay-Hague, and R. R. Brutkiewicz CD44 Differentially Activates Mouse NK T Cells and Conventional T Cells J. Immunol., July 1, 2006; 177(1): 268 - 279. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 A. Fanning, Y. Volkov, M. Freeley, D. Kelleher, and A. Long CD44 cross-linking induces protein kinase C-regulated migration of human T lymphocytes Int. Immunol., April 1, 2005; 17(4): 449 - 458. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
R. J. McKallip, M. Fisher, U. Gunthert, A. K. Szakal, P. S. Nagarkatti, and M. Nagarkatti Role of CD44 and Its v7 Isoform in Staphylococcal Enterotoxin B-Induced Toxic Shock: CD44 Deficiency on Hepatic Mononuclear Cells Leads to Reduced Activation-Induced Apoptosis That Results in Increased Liver Damage Infect. Immun., January 1, 2005; 73(1): 50 - 61. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 G. Yu, H. Luo, Y. Wu, and J. Wu EphrinB1 Is Essential in T-cell-T-cell Co-operation during T-cell Activation J. Biol. Chem., December 31, 2004; 279(53): 55531 - 55539. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 S.-C. Lee, H.-J. Harn, T.-S. Lin, K.-T. Yeh, Y.-C. Liu, C.-S. Tsai, and Y.-L. Cheng Prognostic significance of CD44v5 expression in human thymic epithelial neoplasms Ann. Thorac. Surg., July 1, 2003; 76(1): 213 - 218. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
R. A. O'Connor and E. Devaney Nitric Oxide Limits the Expansion of Antigen-Specific T Cells in Mice Infected with the Microfilariae of Brugia pahangi Infect. Immun., November 1, 2002; 70(11): 5997 - 6004. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
R. J. McKallip, Y. Do, M. T. Fisher, J. L. Robertson, P. S. Nagarkatti, and M. Nagarkatti Role of CD44 in activation-induced cell death: CD44-deficient mice exhibit enhanced T cell response to conventional and superantigens Int. Immunol., September 1, 2002; 14(9): 1015 - 1026. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 S. Khaldoyanidi, S. Karakhanova, J. Sleeman, P. Herrlich, and H. Ponta CD44 variant-specific antibodies trigger hemopoiesis by selective release of cytokines from bone marrow macrophages Blood, May 13, 2002; 99(11): 3955 - 3961. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 L. Yang, X.-F. Qin, D. Baltimore, and L. Van Parijs Generation of functional antigen-specific T cells in defined genetic backgrounds by retrovirus-mediated expression of TCR cDNAs in hematopoietic precursor cells PNAS, April 30, 2002; 99(9): 6204 - 6209. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
X.-Y. Zhou, Y. Yashiro-Ohtani, M. Nakahira, W. R. Park, R. Abe, T. Hamaoka, M. Naramura, H. Gu, and H. Fujiwara Molecular Mechanisms Underlying Differential Contribution of CD28 Versus Non-CD28 Costimulatory Molecules to IL-2 Promoter Activation J. Immunol., April 15, 2002; 168(8): 3847 - 3854. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
M. Suzuki, H. Kobayashi, M. Fujie, T. Nishida, M. Takigawa, N. Kanayama, and T. Terao Kunitz-type Protease Inhibitor Bikunin Disrupts Phorbol Ester-induced Oligomerization of CD44 Variant Isoforms Containing Epitope v9 and Subsequently Suppresses Expression of Urokinase-type Plasminogen Activator in Human Chondrosarcoma Cells J. Biol. Chem., March 1, 2002; 277(10): 8022 - 8032. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
S. Fiorucci, A. Mencarelli, B. Palazzetti, E. Distrutti, N. Vergnolle, M. D. Hollenberg, J. L. Wallace, A. Morelli, and G. Cirino Proteinase-activated receptor 2 is an anti-inflammatory signal for colonic lamina propria lymphocytes in a mouse model of colitis PNAS, November 20, 2001; 98(24): 13936 - 13941. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
J. Mestas and C. C. W. Hughes Endothelial Cell Costimulation of T Cell Activation Through CD58-CD2 Interactions Involves Lipid Raft Aggregation J. Immunol., October 15, 2001; 167(8): 4378 - 4385. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 R. Singh, B.J. Campbell, L.-G. Yu, D.G. Fernig, J.D. Milton, R.A. Goodlad, A.J. FitzGerald, and J.M. Rhodes Cell surface-expressed Thomsen-Friedenreich antigen in colon cancer is predominantly carried on high molecular weight splice variants of CD44 Glycobiology, July 1, 2001; 11(7): 587 - 592. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
D. Chen, R. J. McKallip, A. Zeytun, Y. Do, C. Lombard, J. L. Robertson, T. W. Mak, P. S. Nagarkatti, and M. Nagarkatti CD44-Deficient Mice Exhibit Enhanced Hepatitis After Concanavalin A Injection: Evidence for Involvement of CD44 in Activation-Induced Cell Death J. Immunol., May 15, 2001; 166(10): 5889 - 5897. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
D. Snider and H. Liang Early Intestinal Th1 Inflammation and Mucosal T Cell Recruitment During Acute Graft-Versus-Host Reaction J. Immunol., May 15, 2001; 166(10): 5991 - 5999. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
S. L. Blass, E. Pure, and C. A. Hunter A Role for CD44 in the Production of IFN-{{gamma}} and Immunopathology During Infection with Toxoplasma gondii J. Immunol., May 1, 2001; 166(9): 5726 - 5732. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 N Foger, R Marhaba, and M Zoller Involvement of CD44 in cytoskeleton rearrangement and raft reorganization in T cells J. Cell Sci., January 3, 2001; 114(6): 1169 - 1178. [Abstract] [PDF]
|
|
|
|
|
|
D. A. Witherden, R. Boismenu, and W. L. Havran CD81 and CD28 Costimulate T Cells Through Distinct Pathways J. Immunol., August 15, 2000; 165(4): 1902 - 1909. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
P. Drillenburg and S. T. Pals Cell adhesion receptors in lymphoma dissemination Blood, March 15, 2000; 95(6): 1900 - 1910. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
Y. Yashiro-Ohtani, X.-Y. Zhou, K. Toyo-oka, X.-G. Tai, C.-S. Park, T. Hamaoka, R. Abe, K. Miyake, and H. Fujiwara Non-CD28 Costimulatory Molecules Present in T Cell Rafts Induce T Cell Costimulation by Enhancing the Association of TCR with Rafts J. Immunol., February 1, 2000; 164(3): 1251 - 1259. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
X.-Y. Zhou, Y. Yashiro-Ohtani, K. Toyo-oka, C.-S. Park, X.-G. Tai, T. Hamaoka, and H. Fujiwara CD5 Costimulation Up-Regulates the Signaling to Extracellular Signal-Regulated Kinase Activation in CD4+CD8+ Thymocytes and Supports Their Differentiation to the CD4 Lineage J. Immunol., February 1, 2000; 164(3): 1260 - 1268. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
S. Seiter, D.-S. Schmidt, and M. Zoller The CD44 variant isoforms CD44v6 and CD44v7 are expressed by distinct leukocyte subpopulations and exert non-overlapping functional activities Int. Immunol., January 1, 2000; 12(1): 37 - 49. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 N. L. W. Van Hal, G. A. M. S. Van Dongen, C. B. M. Ten Brink, K.-H. Heider, I. Rech-Weichselbraun, G. B. Snow, and R. H. Brakenhoff Evaluation of Soluble CD44v6 as a Potential Serum Marker for Head and Neck Squamous Cell Carcinoma Clin. Cancer Res., November 1, 1999; 5(11): 3534 - 3541. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
H. Ishiwatari-Hayasaka, T. Fujimoto, T. Osawa, T. Hirama, N. Toyama-Sorimachi, and M. Miyasaka Requirements for Signal Delivery Through CD44: Analysis Using CD44-Fas Chimeric Proteins J. Immunol., August 1, 1999; 163(3): 1258 - 1264. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
K. A. Fitzgerald and L. A. J. O'Neill Characterization of CD44 Induction by IL-1: A Critical Role for Egr-1 J. Immunol., April 15, 1999; 162(8): 4920 - 4927. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
E. A. Wolff, B. Greenfield, D. D. Taub, W. J. Murphy, K. L. Bennett, and A. Aruffo Generation of Artificial Proteoglycans Containing Glycosaminoglycan-modified CD44. DEMONSTRATION OF THE INTERACTION BETWEEN RANTES AND CHONDROITIN SULFATE J. Biol. Chem., January 22, 1999; 274(4): 2518 - 2524. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
S. Ilangumaran, A. Briol, and D. C. Hoessli CD44 Selectively Associates With Active Src Family Protein Tyrosine Kinases Lck and Fyn in Glycosphingolipid-Rich Plasma Membrane Domains of Human Peripheral Blood Lymphocytes Blood, May 15, 1998; 91(10): 3901 - 3908. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
B. M. Sandmaier, R. Storb, K. L. Bennett, F. R. Appelbaum, and E. B. Santos Epitope Specificity of CD44 for Monoclonal Antibody-Dependent Facilitation of Marrow Engraftment in a Canine Model Blood, May 1, 1998; 91(9): 3494 - 3502. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 T. P. Skelton, C. Zeng, A. Nocks, and I. Stamenkovic Glycosylation Provides Both Stimulatory and Inhibitory Effects on Cell Surface and Soluble CD44 Binding to Hyaluronan J. Cell Biol., January 26, 1998; 140(2): 431 - 446. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
R. Schmits, J. Filmus, N. Gerwin, G. Senaldi, F. Kiefer, T. Kundig, A. Wakeham, A. Shahinian, C. Catzavelos, J. Rak, et al. CD44 Regulates Hematopoietic Progenitor Distribution, Granuloma Formation, and Tumorigenicity Blood, September 15, 1997; 90(6): 2217 - 2233. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
M. Zoller, A. Schmidt, A. Denzel, and J. Moll Constitutive Expression of a CD44 Variant Isoform on T Cells Facilitates Regaining of Immunocompetence in Allogeneic Bone Marrow Transplantation Blood, July 15, 1997; 90(2): 873 - 885. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
J. M. Weiss, J. Sleeman, A. C. Renkl, H. Dittmar, C. C. Termeer, S. Taxis, N. Howells, M. Hofmann, G. Kohler, E. Schopf, et al. An Essential Role for CD44 Variant Isoforms in Epidermal Langerhans Cell and Blood Dendritic Cell Function J. Cell Biol., June 2, 1997; 137(5): 1137 - 1147. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
A. Rafi, M. Nagarkatti, and P. S. Nagarkatti Hyaluronate-CD44 Interactions Can Induce Murine B-Cell Activation Blood, April 15, 1997; 89(8): 2901 - 2908. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 M. Pihlgren, P. M. Dubois, M. Tomkowiak, T. Sjogren, and J. Marvel Resting Memory CD8+ T Cells are Hyperreactive to Antigenic Challenge In Vitro J. Exp. Med., December 15, 1996; 184(6): 2141 - 2152. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
T. E. I. Taher, L. Smit, A. W. Griffioen, E. J. M. Schilder-Tol, J. Borst, and S. T. Pals Signaling through CD44 Is Mediated by Tyrosine Kinases J. Biol. Chem., February 2, 1996; 271(5): 2863 - 2867. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
A Bartolazzi, D Jackson, K Bennett, A Aruffo, R Dickinson, J Shields, N Whittle, and I Stamenkovic Regulation of growth and dissemination of a human lymphoma by CD44 splice variants J. Cell Sci., January 4, 1995; 108(4): 1723 - 1733. [Abstract] [PDF]
|
|
|
|
 |
|
 R Arch, K Wirth, M Hofmann, H Ponta, S Matzku, P Herrlich, and M Zoller Participation in normal immune responses of a metastasis-inducing splice variant of CD44 Science, July 31, 1992; 257(5070): 682 - 685. [Abstract] [PDF]
|
|
|
|
|
|
D. Webb, Y Shimizu, G. Van Seventer, S Shaw, and T. Gerrard LFA-3, CD44, and CD45: physiologic triggers of human monocyte TNF and IL-1 release Science, September 14, 1990; 249(4974): 1295 - 1297. [Abstract] [PDF]
|
|
|
|
|
|
R. Li, N. Wong, M. D. Jabali, and P. Johnson CD44-initiated Cell Spreading Induces Pyk2 Phosphorylation, Is Mediated by Src Family Kinases, and Is Negatively Regulated by CD45 J. Biol. Chem., July 27, 2001; 276(31): 28767 - 28773. [Abstract] [Full Text] [PDF]
|
|
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
